精准肝切除治疗邻近重要管道肝肿瘤的临床疗效

Clinical efficacy of precise liver resection of liver tumors adjacent to the main pipeline

  • 摘要: 目的:探讨精准肝切除术治疗邻近重要管道肝肿瘤的临床疗效。
    方法:采用回顾性描述性研究方法。收集2014年12月至2016年6月郑州大学附属肿瘤医院收治的22例邻近重要管道肝肿瘤行精准切除术患者的临床资料。术前精准评估,术中充分暴露肿瘤,适时选择不同血流阻断方法,根据肿瘤部位、大小、与血管的关系以及肝硬化程度等因素综合评估行精准肝切除术。观察患者手术方式、手术时间、肝切除时间、术中出血量、围术期输血例数、术后并发症、术后住院时间及随访情况。采用门诊或电话方式进行随访。肝细胞癌患者前3个月每个月复查AFP,以及肝脏彩色多普勒超声或CT检查监测肿瘤复发情况;胆管细胞癌患者每个月复查肿瘤标志物,以及肝脏彩色多普勒超声或CT检查监测肿瘤复发情况,无复发患者 3个月后每2个月复查1次。肝血管瘤患者出院后每2~3个月随访1次,半年后每6个月随访1次,随访内容包括肝功能、超声等影像学检查,了解患者复发情况。随访时间截至2016年9月。符合正态分布的计量资料以±s表示。
    结果:22例患者均顺利完成精准肝切除术。22例患者中,20例术中采用彩色多普勒超声探查定位。22例患者血流阻断方法:Pringle法行入肝血流全阻断6例、预先处理相应肝蒂3例、选择性半肝血流阻断8例、全肝血流阻断2例、未行肝门阻断3例。22例患者肝切除方式:右三叶切除1例、左半肝切除 2例、肝Ⅳa段切除2例、肝Ⅳ段切除2例、肝Ⅴ段切除3例、肝Ⅷ段切除3例、肝中叶切除1例、局部肝切除8例。22例患者手术时间为(213±39)min,肝切除时间为(57±19)min,术中出血量为(518±98)mL,围术期输血3例。22例患者中,5例术后发生并发症,其中术区积液2例、右侧胸腔积液2例、胆汁漏1例,均经对症治疗后好转。22例患者术后住院时间为(8.9±1.6)d。术后21例患者获得随访,随访时间为3~20个月,中位随访时间为12个月。随访期间2例患者复发,无术区边缘复发患者。
    结论:邻近第一和第二肝门部肝肿瘤患者行精准肝切除术安全可行,其具有术中出血量少、术后并发症发生率低等优点。

     

    Abstract: Objective:To investigate the clinical efficacy of precise liver resection of liver tumors adjacent to the main pipeline.
    Methods:The retrospective and descriptive study was conducted. The clinical data of 22 patients who underwent precise resection of liver tumors adjacent to the main pipeline in the Affiliated Tumor Hospital of Zhengzhou University between December 2014 and June 2016 were collected. According to preoperative precise evaluation and fully intraoperative exposed tumors, different methods of blood flow occlusion were choosed timely, and then precise resection of the liver was evaluated based on tumor location and size, relationship between tumor and blood vessels and the degree of liver cirrhosis. The operation procedures, operation time, time of liver resection, volume of intraoperative blood loss, number of patients with perioperative blood transfusion, postoperative complications, duration of postoperative hospital stay and followup were observed. The followup was performed by outpatient examination and telephone interview up to September 2016. Tumor recurrence of patients with hepatocellular carcinoma (HCC) was monthly detected by alphafetoprotein retest and color Doppler ultrasound of the liver or computed tomography (CT) within 3 months postoperatively. Tumor recurrence of patients with cholangiocarcinoma was monthly detected by tumor marker retests, color Doppler ultrasound of the liver or CT, and then patients without tumor recurrence received reexamination once every 2 months after 3 months. Patients with liver hemangioma were followed up once every 2-3 months and once every 6 months after half a year, and followup included the liver function, ultrasound and other imaging examinations to detect the tumor recurrence. Measurement data with normal distribution were represented as ±s.
    Results:All the 22 patients underwent successful precise resection of liver tumors. Twenty patients received intraoperative ultrasound localization. Blood flow occlusion of 22 patients: Pringle was conducted in 6 patients, treatment of the corresponding hepatic pedicle in 3 patients, selective hepatic blood flow occlusion in 8 patients, total hepatic blood flow occlusion in 2 patients and nonhepatic portal occlusion in 3 patients. Precise resection of the liver of 22 patients: 1 patient underwent right trisegmentectomy, 2 underwent left hepatectomy, 2 underwent segment Ⅳa resection of the liver, 2 underwent segment Ⅳ resection of the liver, 3 underwent segment Ⅴ resection of the liver, 3 underwent segment Ⅷ resection of the liver, 1 underwent middle lobe resection of the liver and 8 underwent partial resection of the liver. Operation time, time of liver resection, volume of intraoperative blood loss and number of patients with perioperative blood transfusion were (213±39)minutes, (57±19)minutes, (518± 98)mL and 3, respectively. Of 22 patients, 5 with postoperative complications were improved after symptomatic treatment, including 2 with effusion at surgical site, 2 with right pleural effusion and 1 with bile leakage. The duration of postoperative hospital stay of 22 patients was (8.9±1.6)days. Twentyone patients were followed up for 3-20 months, with a median time of 12 months. Two of 22 patients had recurrence during the followup, and no recurrence at surgical site was detected.
    Conclusion:Precise resection of liver tumors adjacent to the first and second hepatic hilum is safe and feasible, with the advantages of less intraoperative bleeding and low incidence of postoperative complications.

     

/

返回文章
返回